Azalea Vision Raises €9 Million in First Closing of Series A Funding; Appoints Robert J. Dempsey as Chairman of the Board

GHENT, Belgium—Azalea Vision, a health tech company developing a platform for medical-grade smart lenses that sense, adapt and interact in real time, scaling from vision correction to biosensing and diagnostics, announced that it raised €9 million during the first closing of its €15 million Series A funding round. As part of the company’s strategy for future expansion, Azalea also announced the appointment of Robert J. Dempsey as chairman of the board, where his strong track record across anterior and posterior segments will position him as a key expert in advancing ophthalmic innovation and helping guide strategic growth in European and U.S. markets, the company noted.